Home › Trial NCT00625352
Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma
- Trial IDNCT00625352
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorUlsan University Hospital
- Enrollment48
- Start date2008-02
- ConditionsCarcinoma, Non-Small-Cell Lung
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.